Experimental models and observational studies suggest that homocysteine-lowering therapy with folic acid (FA) may prevent cardiovascular disease (CVD). However, FA also stimulates cell proliferation and might promote progression of atherosclerosis….
Heavy snowfall, cold temperatures, and low atmospheric pressure during the winter months have been associated with increased adverse cardiovascular events. However, only a few cases of the “snow shoveler’s infarction”…
We tested whether the “Lund” (LU) electrode-placement system compared to the Mason-Likar (M-L) electrode-placement system would produce waveforms more similar to those of standard electrocardiograms (ECGs) with regard to the…
In the provocative review by the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) investigators, a single daily dose of valsartan reduced the risk for diabetes by 14%…
Abbate et al report success in limiting adverse cardiac remodeling after acute myocardial infarction by blockade of interleukin-1. This promising new approach used anakinra, a natural substance. Their report also…
The cardiovascular risk reduction associated with different statins for the prevention of cardiovascular disease and the cardiovascular risk increase associated with excess dietary intake of fat have been quantified. However,…
Practitioners and investigators often view clinical trials from very different perspectives—the former in terms of individuals and the latter in terms of groups. The following whimsical dialogue highlights the philosophical…
We read with interest the report by Zagol and Krasuski on motorized scooters. The investigators suggested that scooters can have detrimental long-term effects on cardiovascular risk and that their findings…
